Search details
1.
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL).
Ann Hematol
; 99(7): 1583-1594, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32506244
2.
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Ann Hematol
; 98(8): 1961-1972, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31065733
3.
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
Ann Hematol
; 97(4): 669-678, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29318369
4.
Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP.
EJHaem
; 1(1): 170-180, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-35847728
5.
The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group.
Leuk Res
; 73: 29-38, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30195062
6.
Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT.
Bone Marrow Transplant
; 56(3): 709-712, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32884117
7.
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database.
Leuk Lymphoma
; 57(5): 1094-103, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26293000
8.
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
Leuk Lymphoma
; 56(8): 2350-6, 2015.
Article
in English
| MEDLINE | ID: mdl-25426666
9.
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.
Leuk Lymphoma
; 56(1): 57-64, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-24628294
10.
Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database.
Leuk Lymphoma
; 55(4): 802-10, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-23772666
Results
1 -
10
de 10
1
Next >
>>